Abano Appoints Second Australian Director
Abano Healthcare Group (NZX:ABA) has today announced the appointment of Dr Ginni Mansberg as an independent director effective from 24 August 2016.
Dr Mansberg is a Sydney-based GP with a successful clinical practice. She is a member of the Australian Institute of Company Directors and sits on a number of corporate and not for profit Advisory Boards, including the Australian Cervical Cancer Foundation, and the Australian Immunization Coalition as well as being an ambassador for Barnardos Mother of the Year.
She will be the second Australian-based director to join the Abano Board, as the listed healthcare company concentrates on growing its share of the $11-billion trans-Tasman dental market.
Chairman of Abano, Mr Trevor Janes, said: “Over 50% of Abano’s gross revenues are generated from our Australian dental business and that will continue to grow as we invest into expanding our network. Innovative marketing, effective patient communication and providing an exemplary patient experience are proven elements in the success in our dental businesses. These are also an important part of our future strategy in Australia as we rollout the new national Maven Dental Group brand.
“The Abano Board regular reviews membership to ensure appropriate capabilities, expertise, experience and knowledge are in place to provide effective oversight of Abano’s growth strategy. An external review of the Board was undertaken in early 2016 with very positive results. Dr Mansberg’s experience working in advisory roles in the healthcare sector and running her own successful medical practice, as well as her competence in communication and public affairs add new and valuable skills to the Abano Board.”
Dr Mansberg has experience in medical journalism and is a former political advisor and speech writer. She appears regularly on radio and television, writes for lifestyle and medical magazines and is the author of several books.
She has been appointed by the current Abano Directors, as permitted under Abano’s constitution. She will hold office until Abano’s 2016 Annual Meeting at which time she will offer herself for election by shareholders. The Board has determined that Dr Mansberg is an independent director, for the purposes of NZX Listing Rule 3.3.2. Following Dr Mansberg’s appointment, the Board will comprise of six independent Directors.